Episode Details

Scientists have unveiled groundbreaking news on HIV treatment using CAR-T therapy, which reprogrammed patients immune cells to target and destroy the virus. In a phase one study, two out of three participants maintained undetectable or low HIV levels for over a year after stopping daily meds. This one-time treatment, unlike lifelong pills, could potentially work for a larger population and is being developed to be affordable and accessible. Researchers are now investigating why the therapy succeeded in some cases and not others, with no severe side effects reported.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/a346956b94170928